Marilyn Proulx

Marilyn Proulx is an experienced pharmacovigilance consultant currently working at Truliant Consulting since February 2021 and serving as President at MDDP Consulting since January 2018, specializing in drug safety operations. Previously, Marilyn held the position of Drug Safety Associate III at Exelixis from May 2013 to June 2021, where responsibilities included case processing, triage, and collaboration with clinical study teams on a Phase 3 global trial. Prior roles include Senior Pharmacovigilance Associate at Infinity Pharmaceuticals from February 2009 to May 2013, focusing on the submission and reconciliation of serious adverse events from clinical trials, and a Safety Specialist and Clinical Associate at Molecular Insight Pharmaceuticals from January 2008 to January 2009. Marilyn holds a Master of Arts in Women's Health and Health Policy from Suffolk University and a Bachelor of Science in Public Health Education and Promotion from Rhode Island College.